Cargando…
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152993/ https://www.ncbi.nlm.nih.gov/pubmed/34559205 http://dx.doi.org/10.1182/bloodadvances.2021004983 |
| _version_ | 1784717757061791744 |
|---|---|
| author | Anekpuritanang, Tauangtham Klairmont, Matthew M. Gradowski, Joel Hagiwara, Kohei Bailey, Nathanael G. Chandra, Pranil Liu, Yiwei Mulder, Heather L. Easton, John Zhang, Jinghui Martin, Michael G. Owczarczyk, Anna B. Dunlap, Jennifer B. Fan, Guang Press, Richard D. Raess, Philipp W. |
| author_facet | Anekpuritanang, Tauangtham Klairmont, Matthew M. Gradowski, Joel Hagiwara, Kohei Bailey, Nathanael G. Chandra, Pranil Liu, Yiwei Mulder, Heather L. Easton, John Zhang, Jinghui Martin, Michael G. Owczarczyk, Anna B. Dunlap, Jennifer B. Fan, Guang Press, Richard D. Raess, Philipp W. |
| author_sort | Anekpuritanang, Tauangtham |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9152993 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91529932022-05-31 In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported Anekpuritanang, Tauangtham Klairmont, Matthew M. Gradowski, Joel Hagiwara, Kohei Bailey, Nathanael G. Chandra, Pranil Liu, Yiwei Mulder, Heather L. Easton, John Zhang, Jinghui Martin, Michael G. Owczarczyk, Anna B. Dunlap, Jennifer B. Fan, Guang Press, Richard D. Raess, Philipp W. Blood Adv Research Letter American Society of Hematology 2021-12-03 /pmc/articles/PMC9152993/ /pubmed/34559205 http://dx.doi.org/10.1182/bloodadvances.2021004983 Text en © 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Anekpuritanang, Tauangtham Klairmont, Matthew M. Gradowski, Joel Hagiwara, Kohei Bailey, Nathanael G. Chandra, Pranil Liu, Yiwei Mulder, Heather L. Easton, John Zhang, Jinghui Martin, Michael G. Owczarczyk, Anna B. Dunlap, Jennifer B. Fan, Guang Press, Richard D. Raess, Philipp W. In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported |
| title | In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported |
| title_full | In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported |
| title_fullStr | In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported |
| title_full_unstemmed | In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported |
| title_short | In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported |
| title_sort | in a multi-institutional cohort of myeloid sarcomas, nfe2 mutation prevalence is lower than previously reported |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152993/ https://www.ncbi.nlm.nih.gov/pubmed/34559205 http://dx.doi.org/10.1182/bloodadvances.2021004983 |
| work_keys_str_mv | AT anekpuritanangtauangtham inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT klairmontmatthewm inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT gradowskijoel inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT hagiwarakohei inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT baileynathanaelg inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT chandrapranil inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT liuyiwei inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT mulderheatherl inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT eastonjohn inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT zhangjinghui inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT martinmichaelg inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT owczarczykannab inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT dunlapjenniferb inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT fanguang inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT pressrichardd inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported AT raessphilippw inamultiinstitutionalcohortofmyeloidsarcomasnfe2mutationprevalenceislowerthanpreviouslyreported |